mynth
← DATABASE
11/2025Majority

Asker Healthcare Group takes majority stake in Finmed Group

FRANCE Healthcare Services / Hospital Logistics REV €25–50M

Context

Asker Healthcare Group has signed a definitive agreement to acquire 80% of the shares in Finmed Group, marking its strategic entry into the French healthcare market. This transaction serves as a platform acquisition, providing the Swedish-based group with a robust foundation to expand its presence in one of Europe's largest medical device markets. The deal was structured to ensure management continuity, with Finmed's leadership, including Elie Fiani and Jean-Marc Soghomonian, remaining at the helm to drive the next phase of development. The rationale for the operation is highly strategic for both parties: for Asker, Finmed provides critical local expertise and access to a wide network of French hospitals and pharmacies, while for Finmed, the integration into a larger pan-European group provides the financial firepower and technical resources needed to accelerate innovation and pursue its own external growth. The partnership aims to professionalize Finmed's organizational structure and governance while leveraging Asker's centers of excellence to enhance the service offering for French clients.

Finmed Group, which reported an EBITDA margin of [members only] in 2024, is valued in this transaction at an EV/EBITDA multiple of [members only].

-> Deep-dive in Healthcare & Pharma market trends

Target

Founded as a family-led organization, Finmed Group is a prominent French distributor and solution provider for the medical technology sector. The company specializes in the commercialization of medical devices, equipment, and related consumables, operating through a multi-channel model that includes direct sales, specialized resellers, and e-commerce platforms. Finmed serves a broad spectrum of healthcare stakeholders, including pharmacies, public and private hospitals, and various healthcare institutions across France. Its value proposition is centered on the democratization of medical innovation, ensuring that cutting-edge technologies are accessible to both healthcare professionals and patients. The group’s strategy emphasizes operational excellence and customer satisfaction, acting as a trusted intermediary between global medical manufacturers and the domestic healthcare market. By providing integrated services alongside its product portfolio, Finmed supports the modernization of French medical infrastructure, maintaining a strong focus on professional development and corporate social responsibility (CSR) to ensure sustainable impact in the European healthcare landscape.

Ent. Value

[members only]

Equity Value

[members only]

Multiples

EV / Revenue

[members only]

EV / EBITDA

[members only]

EV / EBIT

[members only]

Historical Financials (EUR)

Year
Rev
EBITDA
EBIT
2024
€25–50M
[members only]
[members only]
2023
€25–50M
[members only]
[members only]

Similar deals in Healthcare Services

Similar deals in Healthcare Services
DateAcquirerTargetCountrySector
01/2026SAGARDQUIPMENTFRANCEHealthcare Services
12/2025PHARMA EQUITY GROUPOTIOMDENMARKHealth Tech
11/2025EURAZEOEXCELYAFRANCECRO / Clinical Trials
10/2025EVOLEMAPPERTONFRANCESterilization & Hygiene
05/2025FIVE ARROWSHUBLOFRANCEHealth Tech
04/2025TRANSCARENTACCOLADEUNITED STATESHealth Tech
04/2025KERSIANEOGEN (ANIMAL BIOSECURITY DIVISION)UNITED STATESSterilization & Hygiene
10/2024FULLSCRIPTRUPA HEALTHUNITED STATESHealth Tech
07/2024ARDIANMASCO GROUPITALYHealthcare Services
06/2024PERMIRAPHARMACORDUNITED STATESHealth Tech

REFERENCES

Revenue range: REV €25–50M

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Finmed Group by Asker Healthcare Group are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

FAQ

What transaction does this page cover?

This page covers the acquisition of a majority stake in Finmed Group, a French company specialised in Hospital Logistics, by Asker Healthcare Group in 2025.

What was Finmed Group’s revenue at the time of the deal?

At the time of the transaction, Finmed Group’s annual revenue was estimated within the €25–50M range (FY 2024). Detailed financial figures are available to members.

What sources support the information on this transaction?

Data on this transaction was compiled from the official corporate announcement published by the parties, combined with independent reporting from specialized financial and M&A publications.

What is mynth?

mynth is the first free M&A database dedicated to Small & Mid-Cap transactions. We centralize Enterprise Values, revenue multiples, EBITDA multiples and transaction financials that are typically locked behind five-figure subscriptions on platforms like Capital IQ or Mergermarket. On mynth, searching and browsing deals is completely free. Our mission is simple: make professional-grade valuation intelligence accessible to every M&A advisor, independent consultant, Private Equity professional and student, without the burden of expensive annual licenses.